Hyundai Completes Full Acquisition of Boston Dynamics as BCI Clinical Trials Expand
로보틱스 | Sat Jun 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | 2 sources
Hyundai is taking full ownership of Boston Dynamics, while brain-computer interface clinical trials for ALS patients are expanding.
Analysis
[Hyundai] brought Boston Dynamics fully in-house as a wholly owned subsidiary [2]
- acquired SoftBank's remaining 9.65% stake for $325 million
- exercised the residual put option following its 2021 acquisition of an 80% stake
- converted Boston Dynamics into a 100% subsidiary of Hyundai
[Boston Dynamics] unveiled plans to deploy the electric Atlas humanoid robot in factories [2]
- will publicly demonstrate the electric Atlas at CES 2026
- slated for deployment at the EV plant near Savannah
- Georgia in 2028
- starting with parts sequencing tasks and expanding to complex tasks by 2030
[Hyundai Mobis] internalized the Atlas actuator supply chain [2]
- responsible for producing actuators
- the core hardware of the humanoid robot
- integrated Hyundai's industrial base with the robotics supply chain
- elevated robotics to a manufacturing capability
[UC Davis] sustained long-term operation of a brain-computer interface for an ALS patient [1]
- ALS patient Casey Harrell has used the implant for approximately 3 years since July 2023
- brain electrodes decode speech-related electrical signals into phonemes
- added new features such as privacy mode and profanity filter
[BCI Industry] saw a surge in clinical trial volunteers and China's first medical BCI approval [1]
- a sharp increase in BCI clinical trial volunteers over the past 2 years
- China became the first country to approve a BCI for medical use this year
- evolving into various forms including fully implantable wireless devices